Oxavita S.R.L.
Plant certified by the Brazilian health regulator (ANVISA)
ANVISA, the Brazilian health regulator, holds a valid Good Manufacturing Practice certificate for this plant, covering medical devices (MDSAP audit programme), valid until 2029-01-20. The certificate is issued after an inspection of the plant itself, which is why a foreign regulator names this site: goods made here are allowed on the Brazilian market. The certificate records the site address as LA CALLE CERETTI 3320, CP 1431 CIUDAD AUTÓNOMA DE BUENOS AIRES. Process number 25351171659202476.
- Type
- Manufacturer
- Location
- Buenos Aires, Argentina
- Categories
- Medische en gezondheidszorgbenodigdheden
- Markets
- Argentinië, Brazilië
Listed in a source registry
Verified facts
- manufacturing-practice-certified (green), checked 2026-08-21 ANVISA (Brazilian Health Regulatory Agency), public register of Good Manufacturing Practice certificates (CBPF)
- facility-registered (green), checked 2026-08-17 US FDA device establishment registration (openFDA)
- tax-filing-active (green), checked 2026-08-15 ARCA (Argentine tax authority), full taxpayer status file (Constancia de inscripcion, RG 1817)
- registry-id-verified (green), checked 2026-08-21 Taxpayer status file (Constancia de inscripcion)
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)